SMBC:NASDAQSouthern Missouri Bancorp, Inc. Analysis
Data as of 2026-09-13 - not real-time
$73.26
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Southern Missouri Bancorp, Inc. is priced at $73.26, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 5.3%. RSI sits at 40.9, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $72.12 and resistance at $77.50.
The shares look undervalued, trading on 11.4 times earnings below a sector average of 16.2. Consensus targets land 14.2% above where the shares trade now. Revenue is growing at 7.7% on a 38.0% profit margin. The 1.39% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 13.3%, a beta of 0.42 and a maximum drawdown of 14.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
The shares look undervalued, trading on 11.4 times earnings below a sector average of 16.2. Consensus targets land 14.2% above where the shares trade now. Revenue is growing at 7.7% on a 38.0% profit margin. The 1.39% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 13.3%, a beta of 0.42 and a maximum drawdown of 14.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
Southern Missouri Bancorp SMBC delivered earnings and revenue surprises of +10.Yahoo Finance1monSouthern Missouri Bancorp, Inc.Seeking Alpha1monSouthern Missouri Bancorp: Still Attractive Despite Premium To Tangible Book ValueIn the second...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 67.57
- MACD momentum is negative
- 30-day price change of -5.3%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 11.4 versus sector average of 16.2
- Trading above the 200-day average of 67.57
- Analyst targets imply +14.2% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 11.4 versus sector average of 16.2
- Analyst targets imply +14.2% versus the current price
- Profit margin of 38.0% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth7.70%
Profit Margin37.97%
P/E Ratio11.4
ROE12.65%
ROA1.40%
P/B Ratio1.4
Op. Cash Flow$80.5M
Industry P/E16.2
Technical Analysis
TrendNeutral
RSI40.9
Support$72.12
Resistance$77.50
MA 20$74.10
MA 50$75.79
MA 200$67.57
MACDBearish
VolumeStable
Fear & Greed Index93.14
Valuation
Fair Value$80.14
Target Price$83.67
Upside/Downside14.21%
GradeUndervalued
TypeValue
Dividend Yield1.39%
Risk Assessment
Beta0.42
Volatility13.32%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.